• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

To investigate the function of non-receptor protein tyrosine kinase ARG, and it's role in leukemogenesis

Research Project

Project/Area Number 13671073
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

OKUDA Keiko  Kyoto Prefectural University of Medicine, Medicine, Instructor, 医学部, 助手 (70305572)

Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2002: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 2001: ¥1,600,000 (Direct Cost: ¥1,600,000)
KeywordsLeukemia / Oncogene / ARG / Tyrosine kinase / STI 571
Research Abstract

ARG is a widely expressed tyrosine kinase, while the function is not well understood. In the study, TEL/ARG was used to investigate the function of ARG, and it's role in leukemohenesis
The TEL/ARG oncogene associated with AML is formed by the t (1;2) (q25;p13) reciprocal translocation, fusing part of the TEL gene to the tyrosine kinase, c-ARG. I have demonstrated that the TEL/ARG protein was heavily phosphorylated on tyrosine, increased tyrosine phosphorylation of multiple cellular proteins, and was associated with factor-independent proliferation when expressed in the factor-dependent murine hematopoietic cell line Ba/F3. Using the sublines, I also have reported that the ARG kinase activity is inhibited by the ABL kinase inhibitor, STI571. In an effort to determine the biological effects and investigate signaling of the TEL/ARG protein more precisely, multiple sublines of Ba/F3 cells were generated in which a TEL/ARG Cdna was expressed under the control of a tetracyline-inducible promo … More ter. Treatment of these cells with doxycycline, a tetracy cline analogue, rapidly induced expression of the TEL/ARG protein. The Ba/F3 -tet- TEL/ARG cells remained IL-3 dependent without doxycycline, but with doxycycline displayed a marked reduction in cell death in the absence IL-3. TEL/ARG cells also displayed an enhanced proliferative response to IL-3 and to IGF-1. Some of the signaling pathways activated by TEL/ARG were compared to those activated by other TEL-tyrosine kinase oncogenes in Ba/F3 cells, inctuding TEL/ABL, TEL/JAK2 and TEL/PDGFRβ. TEL//ARG was heavily phosphorylated on tyrosine residues, and was also found to induce tyrosine phosphorylation of multiple cellular proteins, including rasGAP, Cbl, STAT5, paxillin and SHC. Most of these substrates are also phosphorylated in Ba/F3 cells transformed by another oncogenes listed above, indicating that this family of activated tyrosine kinase oncogenes share several comon signaling pathways. At least in Ba/F3 cells, however, TEL/ARG appears to be less likely to induce complete factor independence compared to other TEL/kinase oncogenes. Nonetheless, the hyper-responsiveness to growth factors reported in this study is highly likely to contribute to the pathogenesis of leukemia Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] Okuda K., Weisberg E., Gilliland DG., Griffin JD.: "ARG tyrosine kinase activity is inhibited by STI571"BLOOD. 97. 2440-2448 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Iijima Y., Okuda K., Tojo A., Tri NK., Setoyama M., Sakaki Y., et al.: "Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG"Oncogene. 21. 4374-4383 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Okuba K., Weisberg E., Gilliland D.G. and Griffin J.D.: "ARG tyrosine kinase activity is inhibited by STI571"BLOOD. 97. 2440-2448 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Iijima Y., Okuda K., Tojo A., Tri NK., Setoyama M., Sakaki Y., Asano S., Tokunaga K., Kruh GD. And Sato Y.: "Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG"Oncogene. 21. 4376-4383 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Okuda K., Weisberg E., Gilliland DG., Griffin JD.: "ARG tyrosine kinase activity is inhibited by STI571"BLOOD. 97. 2440-2448 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Iijima Y., Okuda K., Tojo A., Tri NK., Setoyama M., Sakaki Y., et al.: "Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG"Oncogene. 21. 4374-4383 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Okuda K., Weisberg E., Gilliland DG., Griffin JD.: "ARG tyrosine kinase activity is inhibited by STI571"BLOOD. 97. 2440-2448 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi